̽»¨¾«Ñ¡

Xuekang Qi

Xuekang Qi

Postdoctoral Studies
Visiting address: SciLifeLab, Tomtebodavägen 23A, 17121 Solna
Postal address: K7 Onkologi-Patologi, K7 Forskning Lehtiö, 171 77 Stockholm

About me

  • Using novel chemical, thermal and quantitative proteomics technologies to study Acute Lymphoblastic Leukemia (ALL).

Articles

  • Journal article: BLOOD CANCER DISCOVERY. 2024;5(2_Supplement):p30
    Leo IR; Post F; Struyf N; Qi X; Aswad L; Nguyen TT; Tamai M; Akahane K; Pokrovskaja-Tamm K; Erkers T; Inukai T; Lehtiö J; Jafari R
  • Article: CELL DEATH AND DISEASE. 2019;10(2):58
    Yuan J; Chen L; Xiao J; Qi X-K; Zhang J; Li X; Wang Z; Lian Y-F; Xiang T; Zhang Y; Chen M-Y; Bei J-X; Zeng Y-X; Feng L
  • Article: CELL DEATH AND DISEASE. 2018;9(7):761
    Li N; Yang L; Qi X-K; Lin Y-X; Xie X; He G-P; Feng Q-S; Liu L-R; Xie X; Zeng Y-X; Feng L
  • Article: CANCER RESEARCH. 2018;78(13):3469-3483
    Deng C; Lin Y-X; Qi X-K; He G-P; Zhang Y; Zhang H-J; Xu M; Feng Q-S; Bei J-X; Zeng Y-X; Feng L
  • Article: PLOS PATHOGENS. 2018;14(7):e1007208
    Zhang H-J; Tian J; Qi X-K; Xiang T; He G-P; Zhang H; Yu X; Zhang X; Zhao B; Feng Q-S; Chen M-Y; Zeng M-S; Zeng Y-X; Feng L
  • Article: CANCER SCIENCE. 2018;109(5):1710-1722
    Ma W; Feng L; Zhang S; Zhang H; Zhang X; Qi X; Zhang Y; Feng Q; Xiang T; Zeng Y-X
  • Article: THERANOSTICS. 2018;8(8):2202-2216
    Qi X-K; Han H-Q; Zhang H-J; Xu M; Li L; Chen L; Xiang T; Feng Q-S; Kang T; Qian C-N; Cai M-Y; Tao Q; Zeng Y-X; Feng L
  • Article: CANCER LETTERS. 2016;381(1):14-22
    Li N; Feng L; Han H-Q; Yuan J; Qi X-K; Lian Y-F; Kuang B-H; Zhang Y-C; Deng C-C; Zhang H-J; Yao Y-Y; Xu M; He G-P; Zhao B-C; Gao L; Feng Q-S; Chen L-Z; Yang L; Yang D; Zeng Y-X

All other publications

  • Patent: 2023
    Antibody-drug conjugates and application thereof
    Tang W; Qi X; Zhou X; Yan H; Li S; Fan J; Mai S; Yu J-C; Li S
  • Patent: 2022
    Antibody-drug conjugates and uses thereof
    Tang W; Zhou X; Mei X; Yan H; Li S; Fan J; Qi X; Yu J-C; Li S

Grants

  • 3D Multi-Proteomics Strategy to Identify Targets and Mechanisms of Pro-Drug Nucleoside Analogs in Leukemia
    KI Research Foundation Grants 2024-2025
    1 January 2024 - 31 December 2025
  • National Natural Science Foundation of China
    1 January 2019 - 31 December 2022
  • National Natural Science Foundation of China
    1 January 2019 - 31 December 2022
  • National Natural Science Foundation of China
    1 January 2018 - 31 December 2020
  • National Natural Science Foundation of China
    1 January 2017 - 31 December 2020

News from KI

Events from KI